PharmaCyte Biotech, Inc. (NASDAQ:PMCB – Get Free Report)’s share price dropped 0% during mid-day trading on Friday . The stock traded as low as $1.60 and last traded at $1.64. Approximately 8,550 shares traded hands during mid-day trading, a decline of 68% from the average daily volume of 26,475 shares. The stock had previously closed at $1.64.
PharmaCyte Biotech Stock Down 0.0 %
The company’s 50-day simple moving average is $1.70 and its 200-day simple moving average is $1.80. The stock has a market cap of $11.43 million, a price-to-earnings ratio of 2.48 and a beta of -0.21.
PharmaCyte Biotech (NASDAQ:PMCB – Get Free Report) last announced its earnings results on Friday, December 13th. The company reported ($0.29) earnings per share (EPS) for the quarter.
About PharmaCyte Biotech
PharmaCyte Biotech, Inc, a biotechnology company, develops and commercializes cellular therapies for cancer in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer.
Featured Stories
- Five stocks we like better than PharmaCyte Biotech
- Most Volatile Stocks, What Investors Need to Know
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- Industrial Products Stocks Investing
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for PharmaCyte Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaCyte Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
